Clinical trial
Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With…
NCT00125138 · Lundbeck LLC, Industry · Completed
Key facts
| NCT number | NCT00125138 |
|---|---|
| Title | Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease |
| Official title | Safety and Efficacy of Melperone in the Treatment of Patients With Psychosis Associated With Parkinson's Disease |
| Lead sponsor | Lundbeck LLC, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson's Disease, Psychotic Disorders |
| Intervention type | Drug |
| Interventions | Melperone HCl, Placebo |
| Enrollment | 90 |
| Start date | Jul 1, 2005 |
| Primary completion | Mar 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Jul 29, 2005 |
| Last update posted | Jun 17, 2011 |
| Countries | India, Italy, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: